Amy Liao – CEO
Dr. Amy Liao is the President and Chief Operating Officer of GENEWIZ Inc. Amy is a co-founder of GENEWIZ and has held a critical leadership role in the company’s growth since its founding in 1999.
Amy received B.S. in Biochemistry from Nankai University, China, and M.S. in Biochemistry from Tsinghua University, China, before she obtained her Ph.D. in Biochemistry and Cell Biology from SUNY at Stony Brook. Amy did her postdoctoral training in Biochemistry and Cell Biology at Columbia University before she left to found GENEWIZ.
Together with her GENEWIZ team members, Amy worked to expand GENEWIZ both nationally and globally. GENEWIZ is a leading genomics service company providing Sanger DNA sequencing, gene synthesis, next generation sequencing, molecular biology, bioinformatics, and GLP/CLIA regulatory services. Headquartered in South Plainfield, NJ, GENEWIZ is a global enterprise with additional laboratory and office locations in China, UK, Japan, and France.
Amy focuses on providing the customers with the best value propositions and cultivating a value-driven company culture that the GENEWIZ team can identify with. The team’s goal is to be best in the world AND best for the world.
Along with the GENEWIZ co-founder, Dr. Steve Sun, Amy was selected as the New Jersey winner for the Ernst & Young Entrepreneur Of The Year® 2010, the world’s most prestigious business award for entrepreneurs.